Back to HomeBeta

ICD-10 Coding for Adenoid Cystic Carcinoma(C07, C08.0, C50.91)

Complete ICD-10-CM coding and documentation guide for Adenoid Cystic Carcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

ACCCylindroma

Related ICD-10 Code Ranges

Complete code families applicable to Adenoid Cystic Carcinoma

C07-C08Primary Range

Malignant neoplasms of salivary glands

This range includes codes for malignant neoplasms of the major salivary glands, where adenoid cystic carcinoma commonly occurs.

Malignant neoplasm of breast

ACC can also occur in the breast, and this range covers such cases.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C07Malignant neoplasm of parotid glandUse when ACC is confirmed in the parotid gland.
  • Biopsy confirmation showing ACC histology
  • Immunohistochemistry positive for CD117
C08.0Malignant neoplasm of submandibular glandUse when ACC is confirmed in the submandibular gland.
  • Biopsy confirmation showing ACC histology
  • Immunohistochemistry positive for CD117
C50.91Malignant neoplasm of unspecified site of female breastUse when ACC is confirmed in the breast.
  • Biopsy confirmation showing ACC histology
  • Triple-negative breast cancer markers

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for adenoid cystic carcinoma

Essential facts and insights about Adenoid Cystic Carcinoma

The ICD-10 code for adenoid cystic carcinoma varies by location: C07 for parotid gland, C08.0 for submandibular gland, and C50.91 for breast.

Primary ICD-10-CM Codes for adenoid cystic carcinoma

Malignant neoplasm of parotid gland
Billable Code

Decision Criteria

clinical Criteria

  • Biopsy confirms ACC in parotid gland

documentation Criteria

  • Document 'adenoid cystic carcinoma of parotid gland' with biopsy confirmation

Applicable To

  • Adenoid cystic carcinoma of parotid gland

Excludes

  • Benign neoplasm of parotid gland

Clinical Validation Requirements

  • Biopsy confirmation showing ACC histology
  • Immunohistochemistry positive for CD117

Code-Specific Risks

  • Misclassification with other salivary gland neoplasms

Coding Notes

  • Ensure precise site documentation to avoid miscoding.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Encounter for screening for malignant neoplasms of digestive organs

Z12.1
Use for screening context without active malignancy.

Trigeminal neuralgia

G50.0
Use if there is trigeminal nerve involvement.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of submandibular gland

C08.0
Use when ACC is confirmed in the submandibular gland.

Malignant neoplasm of parotid gland

C07
Use when ACC is confirmed in the parotid gland.

Malignant neoplasm of breast, unspecified

C50.9
Use when specific site within the breast is not documented.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Adenoid Cystic Carcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C07.

Impact

Clinical: May affect treatment decisions., Regulatory: Non-compliance with coding guidelines., Financial: Potential for claim denials.

Mitigation Strategy

Educate staff on site-specific coding, Use decision support tools

Impact

Reimbursement: Incorrect coding can lead to denied claims., Compliance: Misclassification affects compliance with coding standards., Data Quality: Impacts accuracy of cancer registry data.

Mitigation Strategy

Ensure biopsy and immunohistochemical confirmation of ACC.

Impact

Lack of specific site documentation can lead to audit findings.

Mitigation Strategy

Implement mandatory site documentation checks.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Adenoid Cystic Carcinoma, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Adenoid Cystic Carcinoma

Use these documentation templates to ensure complete and accurate documentation for Adenoid Cystic Carcinoma. These templates include all required elements for proper coding and billing.

Pathology report for ACC

Specialty: Pathology

Required Elements

  • Tumor size
  • Histology
  • IHC results
  • Molecular findings

Example Documentation

SPECIMEN: Right parotid gland TUMOR SIZE: 2.4 cm HISTOLOGY: Adenoid cystic carcinoma - Growth pattern: 60% cribriform, 40% tubular - Perineural invasion: Present - Margins: Positive at deep margin IHC: CD117 (diffuse 3+), p63 (myoepithelial +), S100 (focal +) MOLECULAR: MYB-NFIB fusion confirmed by FISH GRADE: Grade II (30% solid component)

Examples: Poor vs. Good Documentation

Poor Documentation Example
Salivary gland cancer
Good Documentation Example
Adenoid cystic carcinoma of left parotid gland (C07) with MYB rearrangement by FISH
Explanation
The good example specifies the type of cancer, location, and molecular findings, which are necessary for accurate coding.

Need help with ICD-10 coding for Adenoid Cystic Carcinoma? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more